Published in J Clin Microbiol on May 01, 2004
Evolution of the core and pan-genome of Streptococcus: positive selection, recombination, and genome composition. Genome Biol (2007) 3.10
Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens. Clin Microbiol Rev (2005) 2.36
Shaping a bacterial genome by large chromosomal replacements, the evolutionary history of Streptococcus agalactiae. Proc Natl Acad Sci U S A (2008) 2.06
Multilocus sequence types associated with neonatal group B streptococcal sepsis and meningitis in Canada. J Clin Microbiol (2009) 1.51
Phylogenetic lineages of invasive and colonizing strains of serotype III group B Streptococci from neonates: a multicenter prospective study. J Clin Microbiol (2006) 1.41
Molecular epidemiology of mastitis pathogens of dairy cattle and comparative relevance to humans. J Mammary Gland Biol Neoplasia (2011) 1.40
Analysis of group B streptococcal isolates from infants and pregnant women in Portugal revealing two lineages with enhanced invasiveness. J Clin Microbiol (2007) 1.40
Population structure of invasive and colonizing strains of Streptococcus agalactiae from neonates of six U.S. Academic Centers from 1995 to 1999. J Clin Microbiol (2008) 1.38
Extent of horizontal gene transfer in evolution of Streptococci of the salivarius group. J Bacteriol (2006) 1.36
Peptidoglycan hydrolase fusions maintain their parental specificities. Appl Environ Microbiol (2006) 1.35
Emergence and global dissemination of host-specific Streptococcus agalactiae clones. MBio (2010) 1.35
Evidence for niche adaptation in the genome of the bovine pathogen Streptococcus uberis. BMC Genomics (2009) 1.32
Comparative genomics and the role of lateral gene transfer in the evolution of bovine adapted Streptococcus agalactiae. Infect Genet Evol (2011) 1.26
Serotype III Streptococcus agalactiae from bovine milk and human neonatal infections. Emerg Infect Dis (2004) 1.25
Distribution of serotypes and antimicrobial resistance genes among Streptococcus agalactiae isolates from bovine and human hosts. J Clin Microbiol (2005) 1.16
Molecular characterization of nontypeable group B streptococcus. J Clin Microbiol (2006) 1.14
Molecular subtyping and characterization of bovine and human Streptococcus agalactiae isolates. J Clin Microbiol (2005) 1.09
Diversity and mobility of integrative and conjugative elements in bovine isolates of Streptococcus agalactiae, S. dysgalactiae subsp. dysgalactiae, and S. uberis. Appl Environ Microbiol (2010) 1.05
Identification of a Streptococcus agalactiae serotype III subtype 4 clone in association with adult invasive disease in Hong Kong. J Clin Microbiol (2006) 1.04
Human Streptococcus agalactiae isolate in Nile tilapia (Oreochromis niloticus). Emerg Infect Dis (2009) 1.02
Selection, recombination, and virulence gene diversity among group B streptococcal genotypes. J Bacteriol (2009) 1.01
Characterization of invasive group B streptococcus strains from the greater Toronto area, Canada. J Clin Microbiol (2014) 0.99
A multi locus variable number of tandem repeat analysis (MLVA) scheme for Streptococcus agalactiae genotyping. BMC Microbiol (2011) 0.99
Association of Group B Streptococcus colonization and bovine exposure: a prospective cross-sectional cohort study. PLoS One (2010) 0.95
Acquisition of insertion sequences and the GBSi1 intron by Streptococcus agalactiae isolates correlates with the evolution of the species. J Bacteriol (2005) 0.94
Mobile genetic elements provide evidence for a bovine origin of clonal complex 17 of Streptococcus agalactiae. Appl Environ Microbiol (2007) 0.92
Characterization of fibrinogen binding by glycoproteins Srr1 and Srr2 of Streptococcus agalactiae. J Biol Chem (2013) 0.92
Complete genome sequence of Streptococcus agalactiae strain SA20-06, a fish pathogen associated to meningoencephalitis outbreaks. Stand Genomic Sci (2013) 0.89
Molecular characterization of Streptococcus agalactiae isolated from bovine mastitis in Eastern China. PLoS One (2013) 0.88
Capsular Typing Method for Streptococcus agalactiae Using Whole-Genome Sequence Data. J Clin Microbiol (2016) 0.88
Clonal variability of group B Streptococcus among different groups of carriers in southern Israel. Eur J Clin Microbiol Infect Dis (2006) 0.86
Transcriptomic and genomic evidence for Streptococcus agalactiae adaptation to the bovine environment. BMC Genomics (2013) 0.86
Pilus distribution among lineages of group b streptococcus: an evolutionary and clinical perspective. BMC Microbiol (2014) 0.85
Genomic analysis reveals the molecular basis for capsule loss in the group B Streptococcus population. PLoS One (2015) 0.85
Necrotizing fasciitis in captive juvenile Crocodylus porosus caused by Streptococcus agalactiae: an outbreak and review of the animal and human literature. Epidemiol Infect (2007) 0.84
Changing trends in mastitis. Ir Vet J (2009) 0.83
Clonal Complex 17 Group B Streptococcus strains causing invasive disease in neonates and adults originate from the same genetic pool. Sci Rep (2016) 0.83
Reevaluating the serotype II capsular locus of Streptococcus agalactiae. J Clin Microbiol (2007) 0.83
Diversity of prophage DNA regions of Streptococcus agalactiae clonal lineages from adults and neonates with invasive infectious disease. PLoS One (2011) 0.82
Analysis of Streptococcus agalactiae pan-genome for prevalence, diversity and functionality of integrative and conjugative or mobilizable elements integrated in the tRNA(Lys CTT) gene. Mol Genet Genomics (2015) 0.81
Genome characterization and population genetic structure of the zoonotic pathogen, Streptococcus canis. BMC Microbiol (2012) 0.81
Serotype distribution, population structure and antimicrobial resistance of Group B Streptococcus strains recovered from colonized pregnant women. J Clin Microbiol (2016) 0.80
Association between genotypic diversity and biofilm production in group B Streptococcus. BMC Microbiol (2016) 0.79
Identification of an unusual pattern of global gene expression in group B Streptococcus grown in human blood. PLoS One (2009) 0.77
Genetic diversity and antimicrobial resistance in Streptococcus agalactiae strains recovered from female carriers in the Bucharest area. Mem Inst Oswaldo Cruz (2014) 0.76
Contribution of the RgfD Quorum Sensing Peptide to rgf Regulation and Host Cell Association in Group B Streptococcus. Genes (Basel) (2017) 0.75
Group B streptococcal disease in infants in the first year of life: a nationwide surveillance study in Japan, 2011-2015. Infection (2017) 0.75
MEGA2: molecular evolutionary genetics analysis software. Bioinformatics (2001) 38.50
SplitsTree: analyzing and visualizing evolutionary data. Bioinformatics (1998) 9.87
Sequence type analysis and recombinational tests (START). Bioinformatics (2001) 7.20
NEONATAL SEPSIS AND OTHER INFECTIONS DUE TO GROUP B BETA-HEMOLYTIC STREPTOCOCCI. N Engl J Med (1964) 7.19
Multilocus sequence typing system for group B streptococcus. J Clin Microbiol (2003) 6.22
Beta hemolytic streptococcus group B associated with problems of the perinatal period. Am J Obstet Gynecol (1961) 5.54
Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proc Natl Acad Sci U S A (2002) 5.28
Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease. Mol Microbiol (2002) 4.82
Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention. MMWR Recomm Rep (1996) 4.71
A SEROLOGICAL DIFFERENTIATION OF SPECIFIC TYPES OF BOVINE HEMOLYTIC STREPTOCOCCI (GROUP B). J Exp Med (1934) 4.56
Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease. Proc Natl Acad Sci U S A (1989) 3.66
Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. Pediatrics (1997) 3.01
The incidence of GBS disease in neonates in different countries. Antibiot Chemother (1971) (1985) 1.57
The importance of group B streptococci as human pathogens in the British Isles. J Clin Pathol (1971) 1.54
ACOG Committee Opinion No. 485: Prevention of early-onset group B streptococcal disease in newborns. Obstet Gynecol (2011) 1.53
Neonatal meningitis in England and Wales: 10 years on. Arch Dis Child Fetal Neonatal Ed (2001) 1.41
Population-based active surveillance for neonatal group B streptococcal infections in Alberta, Canada: implications for vaccine formulation. Pediatr Infect Dis J (2001) 1.30
Characterization of Streptococcus agalactiae isolates of bovine and human origin by randomly amplified polymorphic DNA analysis. J Clin Microbiol (2000) 1.23
Strain differentiation of isolates of streptococci from bovine mastitis by pulsed-field gel electrophoresis. Mol Cell Probes (1997) 1.12
Human and bovine group B streptococci: two distinct populations. J Appl Bacteriol (1984) 1.11
Epidemiological aspects of human/animal interrelationship in GBS. Antibiot Chemother (1971) (1985) 0.98
Streptococcal ecovars associated with different animal species: epidemiological significance of serogroups and biotypes. J Appl Bacteriol (1991) 0.97
A contribution to the research of infection of cows and humans with Streptococcus agalactiae. Zentralbl Bakteriol Mikrobiol Hyg B (1981) 0.91
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet (2009) 15.15
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study. Lancet Infect Dis (2012) 7.18
Multilocus sequence typing system for group B streptococcus. J Clin Microbiol (2003) 6.22
Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis (2003) 5.73
Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans. Nat Med (2003) 4.64
A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat Genet (2007) 4.23
Multilocus sequence typing of Clostridium difficile. J Clin Microbiol (2009) 4.16
Metrics: Do metrics matter? Nature (2010) 4.06
Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity. J Infect Dis (2008) 3.98
A pilot study of rapid benchtop sequencing of Staphylococcus aureus and Clostridium difficile for outbreak detection and surveillance. BMJ Open (2012) 3.93
Genomic islands: tools of bacterial horizontal gene transfer and evolution. FEMS Microbiol Rev (2008) 3.80
Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial. Lancet Infect Dis (2012) 3.71
Vaccine escape recombinants emerge after pneumococcal vaccination in the United States. PLoS Pathog (2007) 3.65
Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection. Lancet Infect Dis (2013) 3.56
Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J Infect Dis (2004) 3.31
Evolutionary dynamics of Staphylococcus aureus during progression from carriage to disease. Proc Natl Acad Sci U S A (2012) 3.29
Silent nucleotide polymorphisms and a phylogeny for Mycobacterium tuberculosis. Emerg Infect Dis (2004) 3.15
Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection. Clin Infect Dis (2013) 3.15
Whole-genome sequencing shows that patient-to-patient transmission rarely accounts for acquisition of Staphylococcus aureus in an intensive care unit. Clin Infect Dis (2013) 3.05
MBL genotype and risk of invasive pneumococcal disease: a case-control study. Lancet (2002) 2.87
Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites. J Infect Dis (2005) 2.66
Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PLoS One (2010) 2.57
Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children. J Infect Dis (2006) 2.54
Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study. BMJ (2006) 2.37
The global burden of disease due to occupational carcinogens. Am J Ind Med (2005) 2.34
After Helsinki: a multidisciplinary review of the relationship between asbestos exposure and lung cancer, with emphasis on studies published during 1997-2004. Pathology (2004) 2.26
Effect of antibiotic prescribing on antibiotic resistance in individual children in primary care: prospective cohort study. BMJ (2007) 2.19
Characterisation of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typing. PLoS Med (2012) 2.12
Clinical Clostridium difficile: clonality and pathogenicity locus diversity. PLoS One (2011) 2.04
Microevolutionary analysis of Clostridium difficile genomes to investigate transmission. Genome Biol (2012) 2.04
High follicular fluid adenosine levels may be pivotal in the metabolism and recycling of adenosine nucleotides in the human follicle. Metabolism (2010) 1.99
Transferable antibiotic resistance elements in Haemophilus influenzae share a common evolutionary origin with a diverse family of syntenic genomic islands. J Bacteriol (2004) 1.93
Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57. AIDS (2002) 1.92
Stability of serotypes during nasopharyngeal carriage of Streptococcus pneumoniae. J Clin Microbiol (2003) 1.78
Type IV secretion systems: tools of bacterial horizontal gene transfer and virulence. Cell Microbiol (2008) 1.78
Climate crunch: Sucking it up. Nature (2009) 1.74
Multilocus sequence typing of serotype III group B streptococcus and correlation with pathogenic potential. J Infect Dis (2004) 1.73
Molecular analysis of the beta-globin gene cluster in the Niokholo Mandenka population reveals a recent origin of the beta(S) Senegal mutation. Am J Hum Genet (2001) 1.73
Science in three dimensions: the print revolution. Nature (2012) 1.72
Estimating the global burden of low back pain attributable to combined occupational exposures. Am J Ind Med (2005) 1.70
Computing: The quantum company. Nature (2013) 1.70
Hybrid Vibrio vulnificus. Emerg Infect Dis (2005) 1.68
The global burden of non-malignant respiratory disease due to occupational airborne exposures. Am J Ind Med (2005) 1.67
Within-host evolution of Staphylococcus aureus during asymptomatic carriage. PLoS One (2013) 1.67
The global burden of selected occupational diseases and injury risks: Methodology and summary. Am J Ind Med (2005) 1.67
Computer sharing loses momentum. Nature (2014) 1.65
Novel type IV secretion system involved in propagation of genomic islands. J Bacteriol (2006) 1.64
User involvement in the development of a research bid: barriers, enablers and impacts. Health Expect (2007) 1.62
Respiratory infections for which general practitioners consider prescribing an antibiotic: a prospective study. Arch Dis Child (2007) 1.60
Clostridium difficile mixed infection and reinfection. J Clin Microbiol (2011) 1.59
Application of coalescent methods to reveal fine-scale rate variation and recombination hotspots. Genetics (2004) 1.59
Thrombotic events after pediatric liver transplantation. Pediatr Transplant (2009) 1.54
Characterization of genetic and phenotypic diversity of invasive nontypeable Haemophilus influenzae. Infect Immun (2005) 1.53
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51
Predictors of first recurrence of Clostridium difficile infection: implications for initial management. Clin Infect Dis (2012) 1.51
Phasevarions mediate random switching of gene expression in pathogenic Neisseria. PLoS Pathog (2009) 1.48
Enhanced invasiveness of bovine-derived neonatal sequence type 17 group B streptococcus is independent of capsular serotype. Clin Infect Dis (2006) 1.47
Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin. Clin Infect Dis (2012) 1.47
Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multi-fragment recombination event. Nat Genet (2012) 1.43
Medicolegal aspects of the third wave of asbestos-related disease in Australia. Med J Aust (2011) 1.40
Detection of mixed infection from bacterial whole genome sequence data allows assessment of its role in Clostridium difficile transmission. PLoS Comput Biol (2013) 1.38
First insights into the evolution of Streptococcus uberis: a multilocus sequence typing scheme that enables investigation of its population biology. Appl Environ Microbiol (2006) 1.35
Mitochondrial genomics identifies major haplogroups in Aboriginal Australians. Am J Phys Anthropol (2006) 1.33
The global burden due to occupational injury. Am J Ind Med (2005) 1.30
Enhanced determination of Streptococcus pneumoniae serotypes associated with invasive disease in Laos by using a real-time polymerase chain reaction serotyping assay with cerebrospinal fluid. Am J Trop Med Hyg (2010) 1.30
Variation matters: TLR structure and species-specific pathogen recognition. Trends Immunol (2009) 1.28
A systematic mapping review of effective interventions for communicating with, supporting and providing information to parents of preterm infants. BMJ Open (2011) 1.26
Serotype III Streptococcus agalactiae from bovine milk and human neonatal infections. Emerg Infect Dis (2004) 1.25
Functional specialization and ontogenetic scaling of limb anatomy in Alligator mississippiensis. J Anat (2010) 1.24
Risk factors for Clostridium difficile acquisition in infants: importance of study design. Clin Infect Dis (2013) 1.24
Sequence and functional analyses of Haemophilus spp. genomic islands. Genome Biol (2007) 1.23
Deciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes. Am J Hum Genet (2006) 1.23
Genetic diversity and carriage dynamics of Neisseria lactamica in infants. Infect Immun (2005) 1.21
Recombinational switching of the Clostridium difficile S-layer and a novel glycosylation gene cluster revealed by large-scale whole-genome sequencing. J Infect Dis (2012) 1.21
Site-specific recombination with the chromosomal tRNA(Leu) gene by the large conjugative Haemophilus resistance plasmid. Antimicrob Agents Chemother (2002) 1.20
Mechanical complications of acute myocardial infarction. Cardiol Clin (2013) 1.19
Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementation. J Infect Dis (2011) 1.19